Key result
Percutaneous vacuum-assisted aspiration achieves ~82% procedural success for high-risk left-sided cardiac masses.
Why the study?
Outcomes and procedural strategies for percutaneous vacuum-assisted aspiration of left-sided valvular vegetations and intracardiac masses in poor surgical candidates required synthesis, given marked clinical heterogeneity and the limited number of available studies.
Does percutaneous vacuum-assisted aspiration achieve procedural success (>50% reduction in vegetation size) in adults with left-sided valvular vegetations or intracardiac masses who are poor surgical candidates?
Systematic Review (n=33)
Yes
Does percutaneous vacuum-assisted aspiration achieve procedural success (>50% reduction in vegetation size) in adults with left-sided valvular vegetations or intracardiac masses who are poor surgical candidates?
Answers are grounded in this paper and cite their sources.
Percutaneous vacuum-assisted aspiration of left-sided intracardiac masses and endocarditis vegetations demonstrates high technical success (81.8%) and relatively low in-hospital mortality (6.1%) in prohibitive surgical risk patients, though recurrence (22.6%) and periprocedural stroke (9.1%) remain notable risks.
Objective To assess outcomes and procedural strategies for percutaneous vacuum-assisted aspiration of left-sided valvular vegetations and intracardiac masses in adults with infective endocarditis or thrombus who were poor surgical candidates. A systematic scoping review approach was chosen because of marked clinical heterogeneity and the limited number of available studies. Methods We conducted a PRISMA-ScR systematic scoping review of PubMed, EMBASE, and the Cochrane Library from January 1, 2015, to January 16, 2026. Eligible studies reported adult left-sided (mitral, aortic, or left-sided chamber) vegetations or masses treated with percutaneous aspiration or debulking systems. The primary outcome was procedural success, defined as >50% reduction in vegetation size by transesophageal or intracardiac echocardiography. Data were summarized descriptively. Results We screened 195 records and included 22 full-text studies comprising 33 patients from single-center case reports or case series. The transseptal approach was most commonly used (66.7%), followed by transapical (12.1%), retrograde transaortic (9.1%) and transcaval approaches (3%). Infective vegetations accounted for 66.7% of cases. The mitral valve was affected in 82.1% of cases. Vegetation size was reported in 60.6% of cases, with a median size of 18.5 mm (IQR: 15 to 20.5). Procedural success occurred in 81.8%. In-hospital mortality was 6.1%. Subsequent surgery was reported in 9.7%, and persistence or recurrence in 22.6% among the 28 cases with reported follow-up. Conclusion Percutaneous vacuum-assisted aspiration achieved high technical success with low in-hospital mortality, but long-term survival data is limited. Further prospective studies are needed with standardized endpoints and follow-up to define durability, patient selection, and comparative effectiveness to surgery or medical therapy alone.
No takes yet. Share an insight, caveat, or question.
Acharya et al. (2026) conducted a systematic review in Left-sided infective endocarditis or intracardiac thrombotic masses (n=33). Percutaneous vacuum-assisted aspiration / mechanical debulking (AngioVac, Penumbra, or large-bore manual aspiration) was evaluated on Procedural success (>50% reduction in vegetation or mass size by transesophageal or intracardiac echocardiography). Percutaneous vacuum-assisted aspiration achieved 81.8% procedural success and 6.1% in-hospital mortality in poor surgical candidates with left-sided vegetations or masses.
Synapse has enriched 10 related papers. Consider them for comparative context: